Narrow search
Showing 1 - 10 of 184
Cover Image
Competition in off-patent drug markets : issues, regulation and evidence
Kanavos, Panos; Costa-Font, Joan; Seeley, Elizabeth - In: Economic policy : a European forum 55 (2008), pp. 499-544
Persistent link: https://www.econbiz.de/10003741151
Cover Image
Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
Varol, Nebibe - 2014
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of … generic competition following the first global generic launch of each molecule. Drawing upon data from 1999 to 2008, we …
Persistent link: https://www.econbiz.de/10013068052
Cover Image
Is medicines parallel trade "regulatory arbitrage"?
Costa-Font, Joan - 2015
) that accounted for 5% of the market at the time of study and faced no generic competition. Our findings suggest that after … regulation, and not by price differences in line with the hypothesis of "regulatory arbitrage". …
Persistent link: https://www.econbiz.de/10010477153
Cover Image
Is Medicines Parallel Trade 'Regulatory Arbitrage'?
Costa-Font, Joan - 2015
) that accounted for 5% of the market at the time of study and faced no generic competition. Our findings suggest that after … regulation, and not by price differences in line with the hypothesis of ‘regulatory arbitrage' …
Persistent link: https://www.econbiz.de/10013028783
Cover Image
Product differentiation, competition and regulation of new drugs : the case of statins in four European countries
Kanavos, Panos; Costa-Font, Joan; McGuire, Alistair - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 455-465
Persistent link: https://www.econbiz.de/10003543710
Cover Image
Re-visiting the Health Care Luxury Good Hypothesis: Aggregation, Precision, and Publication Biases?
Costa-Font, Joan; Gemmill, Marin; Rubert, Gloria - Facultat d'Economia i Empresa, Universitat de Barcelona - 2008
While a growing literature examining the relationship between income and health expenditures suggests that health care is a luxury good, this conclusion is contentiously debated due to heterogeneity of the existing results. This paper tests the luxury good hypothesis using meta-regression...
Persistent link: https://www.econbiz.de/10005176396
Cover Image
Price regulation and relative delays in generic drug adoption
Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Journal of Health Economics 38 (2014) C, pp. 1-9
regulation has a significant effect on reducing the time to launch of generics, with faster adoption in higher priced markets …. The latter result is dependent on the degree of competition and the expected market size. …
Persistent link: https://www.econbiz.de/10011117216
Cover Image
Price regulation and relative delays in generic drug adoption
Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Journal of health economics 38 (2014), pp. 1-9
Persistent link: https://www.econbiz.de/10011282079
Cover Image
Does pharmaceutical price regulation affect the adoption of generic competition? : evidence from the OECD, 1999-2008
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
strategy in contrast to research-intensive pharmaceutical firms. -- generic competition ; regulation ; adoption ; discrete …Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of …
Persistent link: https://www.econbiz.de/10009124143
Cover Image
Does pharmaceutical price regulation affect the adoption of generic competition? Evidence from the OECD, 1999-2008
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of … generic competition following the first global generic launch of each molecule. Drawing upon data from 1999 to 2008, we …
Persistent link: https://www.econbiz.de/10010274736